Silenor
Insomnia, Neurotic depression, Depression + 8 more
Treatment
20 Active Studies for Silenor
Treatment for
Insomnia
What is Silenor
Doxepin
The Generic name of this drug
Treatment Summary
Doxepin is a medication used to treat depression and anxiety. It belongs to a class of drugs called tricyclic antidepressants, but it does not have the same exact properties as them. Doxepin was first approved by the FDA in 1969 for use as an antidepressant and was later approved in 2010 for the treatment of insomnia. It was developed by Pfizer and is available under the brand name Silenor.
Sinequan
is the brand name
Silenor Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Sinequan
Doxepin
1969
307
Effectiveness
How Silenor Affects Patients
Doxepin is a type of antidepressant that works by decreasing electrical activity in the brain. It can cause antidepressant, sedative, and anticholinergic effects, but at higher doses the anticholinergic and antiadrenergic properties become more prominent. The antidepressant effects of doxepin become noticeable after 2 weeks, while the sedative effects can be seen right away.
How Silenor works in the body
Doxepin works by blocking histamine receptors, which helps to treat skin conditions. Additionally, it works on the central nervous system to increase the activity of norepinephrine and serotonin, which are neurotransmitters. This increases the activity at the post-synaptic neuron receptor sites. Doxepin also desensitizes serotonin 1A receptors and beta-adrenergic receptors. Lastly, it is thought to increase dopamine activity in the frontal cortex.
When to interrupt dosage
The dosage of Silenor is contingent upon the identified condition, including Depression, Involutional, Mental Disorder, Organic and Insomnia. The measure of dosage is contingent upon the technique of application (e.g. Oral or Tablet - Oral) featured in the table beneath.
Condition
Dosage
Administration
Insomnia
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Neurotic depression
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Depression
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Generalized Anxiety Disorder
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Neuropathic Pain
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Itching
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Depressive Disorder, Major
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Behcet Syndrome
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Alcoholism
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Depressive Disorder, Major
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Neurodermatitis
, 10.0 mg/mL, 10.0 mg, 25.0 mg, 50.0 mg, 75.0 mg, 100.0 mg, 0.05 mg/mg, 150.0 mg, 3.0 mg, 6.0 mg, 5.0 %
Oral, , Solution, concentrate, Solution, concentrate - Oral, Capsule - Oral, Capsule, Topical, Cream, Cream - Topical, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, film coated, Tablet, film coated - Oral
Warnings
Silenor Contraindications
Condition
Risk Level
Notes
untreated narrow angle glaucoma
Do Not Combine
Pulse Frequency
Do Not Combine
Urinary Retention
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Doxepin may interact with Pulse Frequency
There are 20 known major drug interactions with Silenor.
Common Silenor Drug Interactions
Drug Name
Risk Level
Description
4-Methoxyamphetamine
Major
Doxepin may increase the vasopressor activities of 4-Methoxyamphetamine.
Acepromazine
Major
Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.
Aclidinium
Major
The risk or severity of adverse effects can be increased when Doxepin is combined with Aclidinium.
Alfuzosin
Major
Doxepin may increase the hypotensive activities of Alfuzosin.
Aripiprazole
Major
Doxepin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.
Silenor Toxicity & Overdose Risk
Taking too much doxepin can cause seizures, irregular heartbeat, unconsciousness, low blood pressure, and depression of the central nervous system. It can also lead to changes in electrocardiogram results and even death. Additionally, doxepin affects fertility in men and women, leading to decreased implantation and litter size, as well as abnormal sperm and reduced sperm motility. There is no evidence that it causes cancer or genetic mutations.
Silenor Novel Uses: Which Conditions Have a Clinical Trial Featuring Silenor?
Currently, 1020 active studies are looking into the potential of Silenor to provide relief from Generalized Anxiety Disorder, Atopic Dermatitis and Bipolar Disorder.
Condition
Clinical Trials
Trial Phases
Generalized Anxiety Disorder
181 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Early Phase 1, Phase 3, Phase 1
Depressive Disorder, Major
0 Actively Recruiting
Insomnia
0 Actively Recruiting
Depression
300 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3
Alcoholism
7 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Neurotic depression
0 Actively Recruiting
Depressive Disorder, Major
0 Actively Recruiting
Itching
3 Actively Recruiting
Phase 3, Not Applicable
Behcet Syndrome
1 Actively Recruiting
Not Applicable
Neuropathic Pain
4 Actively Recruiting
Not Applicable, Phase 1, Phase 2
Neurodermatitis
0 Actively Recruiting
Silenor Reviews: What are patients saying about Silenor?
5
Patient Review
6/15/2016
Silenor for Chronic Trouble Sleeping
5
Patient Review
5/12/2016
Silenor for Chronic Trouble Sleeping
5
Patient Review
2/22/2018
Silenor for Chronic Trouble Sleeping
4.7
Patient Review
3/14/2016
Silenor for Chronic Trouble Sleeping
4.3
Patient Review
9/22/2014
Silenor for Chronic Trouble Sleeping
4.3
Patient Review
10/17/2016
Silenor for Chronic Trouble Sleeping
2.7
Patient Review
4/28/2018
Silenor for Chronic Trouble Sleeping
2.3
Patient Review
5/9/2015
Silenor for Chronic Trouble Sleeping
2.3
Patient Review
8/29/2016
Silenor for Chronic Trouble Sleeping
2.3
Patient Review
12/21/2014
Silenor for Chronic Trouble Sleeping
2
Patient Review
7/24/2018
Silenor for Chronic Trouble Sleeping
1.7
Patient Review
11/6/2016
Silenor for Chronic Trouble Sleeping
1.7
Patient Review
11/1/2015
Silenor for Chronic Trouble Sleeping
1.7
Patient Review
11/10/2019
Silenor for Chronic Trouble Sleeping
1.7
Patient Review
7/24/2018
Silenor for Chronic Trouble Sleeping
1
Patient Review
10/15/2016
Silenor for Chronic Trouble Sleeping
Patient Q&A Section about silenor
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How long does it take for Silenor to kick in?
"After taking doxepin, you should limit your activities to those necessary to prepare for sleep. Doxepin works best when taken 3 hours after a meal and within 30 minutes of bedtime."
Answered by AI
What are the side effects of Silenor?
"trouble sleeping
Drowsiness, dizziness, stuffy nose, sneezing, sore throat, nausea, vomiting, diarrhea, constipation, loss of appetite, and trouble sleeping are all symptoms of the cold."
Answered by AI
Is Silenor a narcotic?
"The manufacturer of Silenor claims that it is a non-abusable option for insomnia relief and is not classified as a controlled substance by the DEA."
Answered by AI